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Objective: Although the results of staged endovascular and open surgical reconstructions have been well documented, the
safety and efficacy of concomitant procedures in the operating room are less well defined. Suboptimal performance of
endovascular procedures in an operative setting, or inappropriate reliance on endovascular techniques, might theoreti-
cally compromise graft patency. We questioned whether late graft thrombosis is frequently attributable to failure at the
endovascularly treated site in this setting.
Materials and Methods: Between May 1, 1993, and June 30, 2001, we performed 125 concomitant endovascular and open
arterial reconstructions (73 primary reconstructions, 52 graft revisions) in 106 patients. Endovascular techniques were
used to treat inflow lesions in 72 cases, outflow lesions in 14 cases, both in four cases, and the graft itself in 35 cases.
Fifty-five iliac, 18 femoral, 13 popliteal, six tibial, and 35 graft lesions were treated. For primary bypasses, 33 were to the
popliteal level (21 prosthetic, 12 autogenous), 19 were to the tibial or pedal arteries (16 autogenous, three prosthetic or
composite), and 12 were to the femoral arteries (one autogenous, 11 prosthetic). Nine patch angioplasties (eight femoral,
one popliteal) were performed. For graft revisions, endovascular intervention was for inflow in 13 cases, outflow in three
cases, both in one case, and of the graft itself in 35 cases. Surgical revisions involved segmental grafts in 33 cases, patch
angioplasty in 18 cases, and both in one case.
Results: In the primary group, the initial technical success rate of the endovascular procedure was 93% (68/73), with five
patients needing open conversion. The 30-day mortality rate was 1.4%, and the morbidity rate was 11.0%. Of the 19 grafts
in the primary group that occluded during the follow-up period (mean, 11.9 months), five thromboses could possibly be
attributed to failure at the endovascular site. In the revision group, the initial technical success rate of the endovascular
procedure was 88% (46/52), with six patients undergoing conversion to open procedure. The 30-day mortality rate was
0%, and the morbidity rate was 15.4%. Of 22 late graft occlusions in the revision group, only three were attributed to
failure at the endovascular site.
Conclusion: This largest report to date of concomitant lower extremity endovascular and open revascularization
procedures shows the approach to be safe. Few late graft occlusions were attributable to failure at the endovascularly
treated site. The concomitant approach offers the efficiency and convenience of single stage therapy and allows immediate
treatment for inadequate endovascular results or their complications and potential cost savings. (J Vasc Surg 2003;37:
316-22.)
Staged surgical revascularization after initial endovas-
cular treatment has become a well-accepted treatment
strategy for more than two decades in patients with multi-
level lower extremity occlusive disease.1-3 However, the
durability of angioplasty in a setting where bypass grafts are
dependent on the endovascular treatment site remains a
reason for concern, as late hemodynamic failure rates of
40% to 65% for angioplasty have been observed in large
prospective series.4-7 As vascular surgeons have embraced
the independent performance of endovascular procedures
in the operating room over the last decade, the concomi-
tant performance of endovascular and open revasculariza-
tion as a single procedure has become more attractive.
However, the published literature on immediate and late
results of combined procedures is somewhat limited (Table
I).3,8-31 Suboptimal performance of endovascular proce-
dures in an operative setting or inappropriate reliance on
endovascular techniques might theoretically compromise
graft patency. We questioned whether the concomitant
approach is safe and whether late graft failure in this setting
is frequently related to failure at the endovascular treatment
site.
METHODS
Vascular surgeons have independently performed cath-
eter-based procedures at Pennsylvania Hospital in a dedi-
cated endovascular operating room since 1993.32 A com-
puterized vascular registry was reviewed to identify patients
undergoing simultaneous endovascular and open treat-
ment for lower extremity arterial disease between May 1,
1993, and June 30, 2001. All procedures were performed
with anesthesia monitoring. Procedures were classified as
BYPASS when a new arterial reconstruction was performed
with adjunctive angioplasty or as REVISION when a pre-
vious reconstruction was treated with combined open and
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endovascular procedures. Demographic data were tabu-
lated. The two groups were separately analyzed as to out-
come events.
Postoperative duplex ultrasound scan surveillance was
routinely used for all reconstructions. Causes and timing of
graft failure were recorded; although causes of occlusion
were not always certain, the status of the endovascular
treatment site was assessed in all cases with operation,
angiography, or noninvasive studies. For nominal variables,
2 analysis was used. Graft patency and limb salvage calcu-
lations were estimated with the Kaplan-Meier life-table
method and compared with the log-rank test. Graft patency
was defined with Society for Vascular Surgery/Interna-
tional Society for Cardiovascular Surgery consensus stan-
dards33,34 and, for the purpose of this analysis, referred to
the status of the operative reconstruction. Technical failure
of concomitant angioplasty procedures was separately ana-
lyzed and reported, but these procedures were not cen-
sored from late patency analysis.
RESULTS
There were 73 procedures in the BYPASS group and 52
in the REVISION group. The total cohort was 106 pa-
tients, with some undergoing bilateral procedures or sec-
ondary reconstructions and some BYPASS patients later
undergoing combined treatment and thus being separately
analyzed as REVISION procedures. Thus, no combined
procedures were excluded from analysis.
No differences were seen between the BYPASS and
REVISION groups in age (mean, 69.3 years), gender
(54.4% male), race (75.2% white), or prevalence of diabetes
mellitus (52.8%), tobacco use (78.4%), hypertension
(76.0%), or hyperlipidemia (47.2%). End stage renal disease
was more common for BYPASS procedures than for REVI-
SION procedures (17.8% versus 5.7%; P  .05).
Patients with combined inflow and outflow disease in
whom an inflow procedure alone might have been suffi-
cient were treated with a single or sequential procedure and
therefore excluded from this analysis. During the time
period reflected in this report, isolated inflow procedures
were performed with an open (n  147) or endovascular
treatment (n  107) approach. The indication for surgery
in the BYPASS group was for limb salvage in 65 procedures,
disabling claudication in six procedures, and popliteal an-
eurysm in two procedures. The open procedure was a
secondary revascularization in 28 of 73 cases (38.3%). For
REVISION procedures, surgical indication was a patent
but failing graft in 34 cases and an acutely thrombosed graft
in 18 cases.
In the BYPASS group, 77 lesions were treated in 73
procedures. The endovascular portion of the procedure was
for inflow in 58 cases, outflow in 11 cases, and both inflow
and outflow lesions in four cases. The angioplasty sites were
the common iliac artery (n 29), external iliac artery (n
16), superficial femoral artery (n  19), popliteal artery
(n 11), and tibial vessels (n 2). Stents were deployed in
16 of 29 common iliac lesions and 13 of 16 external iliac
lesions. The surgical revascularization was most frequently
femoropopliteal (n 33; 12 vein, 21 prosthetic) or infrap-
opliteal (n  19; 16 vein, three prosthetic) bypass.
For the REVISION group, all procedures involved
treatment of at least one lesion surgically and one endovas-
cularly. In many cases, a more severe, longer lesion was
treated surgically and a focal, less severe lesion was treated
endovascularly. Fifty-three lesions were treated with bal-
loon angioplasty in 52 procedures. Grafts were to pedal or
crural arteries (n  27; 22 autogenous, five prosthetic),
popliteal arteries (n  18; 12 autogenous, six prosthetic),
aortofemoral (n 4), femorofemoral (n 2), and iliofem-
oral (n 1). Lesions were in previously placed bypass grafts
in 35 cases (distal anastomosis, 23; proximalanastomosis, 8;
midgraft, 4), inflow arteries in 13 cases, outflow vessels in
three cases, and both inflow and outflow arteries in one
case. Stents were placed in 10 cases (iliac, 8; superficial
femoral, 2). The open surgical procedure was a segmental
bypass graft in 20 procedures, patch angioplasty in 18
procedures, interposition graft in 13 procedures, and both
patch and interposition in one procedure.
Technical success, defined as 30% residual stenosis
and no pressure gradient across the treated lesion, was
Table I. Largest published reports including concomitant open and endovascular lower extremity procedures
Author Year Procedures Endo sites Endo success rate Endo patency rate Graft patency rate
Motarjeme10 1981 21 * 90% * *
Pfeiffer12 1986 70 * 99% * *
Spoelstra14 1989 79 * 85% 80% at 3 y *
Weber15 1989 78 93 97% 77% at 5 y *
Chin16 1989 48 * 98% 58% to 81% at 2 y *
Clement17 1990 44 * 91% * *
AbuRahma19 1992 84 85 95% * 86% at 2 y
Gross23 1996 105 * * * *
Schneider24 1997 21 28 100% * 83% at 1 y
Madera27 1997 108 150 84% to 92% 58% to 100% at 2 y *
Melliere30 1999 64 64 100% * *
Timaran31 2001 87 * 97% 79% at 3 y 63% at 3 y
Dougherty 2002 125 130 91% * 65% at 5 y
Endo success denotes immediate technical success with angioplasty procedure.
*Insufficient data to estimate.
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achieved for the angioplasty procedure in 114 of 125 cases
overall (91.2%). Angioplasty failure was treated with open
conversion in five BYPASS and six REVISION procedures
(Table II); graft placement was used in seven cases, and
patch repair in four.
One cardiac death occurred in the series as whole, for a
mortality rate of 0.8% (1.4% for BYPASS group, 0 for
REVISION group). Morbidity was observed in 16 of the
125 procedures (12.8%), and complications are listed in
Table III. In addition, early graft occlusion (30 days)
occurred in four BYPASS and two REVISION procedures
and is reflected in patency calculations.
In a follow-up period that averaged 27.6 months
(range, 2 to 75 months), graft occlusions occurred in 19
BYPASS patients and 22 REVISION patients. Life-table
survival analysis is shown for the BYPASS group for end-
points of primary patency, assisted primary patency, sec-
ondary patency, and limb salvage (Fig). Subgroup analysis
for patency was limited by sample size but was compared
for stent utilization (n  29 with stent versus 44 without
stent) and iliac angioplasty site (n  45 iliac versus 28
infrainguinal). In comparison of assisted primary patency
for patients with stent placement versus no stent and for
iliac versus infrainguinal angioplasty site, no statistically
significant differences were observed. We also were unable
to discern a difference for inflow versus outflow angio-
plasty, but because the outflow group had only 13 patients,
a type II error was possible.
Twenty-three revisions were performed on patent
grafts in the BYPASS group, in most cases for duplex
scan-diagnosed lesions. Of the 23, seven (30.4%) were for
restenosis at the angioplasty site. These revisions account
for the marked difference in primary and assisted primary
patency survival curves.
For the 19 graft thromboses after BYPASS procedures
(mean, 11.9 months after surgery), restenosis at the angio-
plasty site was noted in five cases and therefore possibly
contributed to graft failure. Angioplasty sites for these
occlusions were the common iliac artery in one case, the
external iliac in one case, and the popliteal in three cases.
There was a statistically significant higher risk of angioplasty
site failure causing graft thrombosis for popliteal or tibial
lesions (n  11) than for more proximal lesions (n  62;
P  .011). Treatment for these failures was repeat angio-
plasty and new graft in three cases, patch revision and
thrombectomy in one case, and no procedure in one case.
For REVISION procedures, patency analysis could not
be performed with the life-table method because of the
variable ages and patency history of the revascularization
procedures revised, but apparent causes of graft failure were
identified. Graft occlusion in the REVISION group oc-
curred at a mean of 7.5 months in 22 grafts. In only three of
these 22 was restenosis noted at the endovascular treatment
site (external iliac, 1; popliteal, 1; tibial, 1). New grafts were
constructed in two cases and a secondary revision was done
in one case, and all have remained patent through a mean
follow-up period of 12.5 months.
For 11 of the 19 thrombosed BYPASS procedures
(57.9%), patients were delinquent for duplex scan surveil-
lance (n  9) or had duplex scan lesions that were being
followed conservatively (n 2) at the time of graft throm-
bosis. This included three of the five procedures where
angioplasty site stenosis contributed to graft occlusion.
Likewise for REVISION procedures, 15 of 22 procedures
(68.2%) in which later thrombosis developed were for
patients who had missed duplex scan surveillance (n  10)
Table II. Angioplasty failure in BYPASS and REVISION groups
Location Graft type Failure reason Treatment
BYPASS
Common iliac Prosthetic femoral-popliteal Extravasation Prosthetic ilio-femoral
External iliac Vein femoral-popliteal Nondilatable Prosthetic ilio-femoral
External iliac Prosthetic femoral-popliteal Dissection Prosthetic ilio-femoral
Superficial femoral artery Vein popliteal-tibial Embolization Thrombectomy/vein
patch
Popliteal Vein popliteal-tibial Nondilatable Vein jump graft
REVISION
Graft-proximal
(superficial femoral artery; n  2)
Vein Nondilatable Vein patch
Graft-distal (tibial) Vein Nondilatable Vein patch
Graft-distal (tibial) Prosthetic Dissection Prosthetic interposition
Graft-distal (peroneal) Vein Rupture Vein interposition
External Iliac artery Vein Dissection Prosthetic interposition







Myocardial infarction 2 1
Wound infection 2 2
Hematoma 1 2
Lymphatic fistula 1 0
Graft infection/erosion 1 1
Pneumonia 1 1
Deep vein thrombosis 0 1
Total moribidity 8 (11.0%) 8 (15.4%)
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or had abnormalities being followed conservatively (n 5).
Two of these were among the three procedures where
angioplasty site restenosis was found to be the cause of graft
occlusion.
DISCUSSION
Over the last decade, vascular surgeons have assumed
an increasing role in the performance of endovascular pro-
cedures. The development of new technologies, such as
intravascular stents and stent grafts, has increased the pool
of patients who can be treated with transluminal therapy.
Increasing age and comorbidities in the population need-
ing lower extremity revascularization has also made the less
invasive approach more attractive.
The complementary use of endovascular procedures
and subsequent surgical revascularization has been vali-
dated in a number of reports.1,2,35-37 Brewster et al1 re-
ported a favorable 76% 5-year graft patency rate in 79
patients treated with preliminary iliac artery angioplasty
followed by interim femorofemoral or femorodistal bypass.
More recently, Faries et al36 observed a 3-year graft patency
rate of 71% in 126 patients treated sequentially with iliac
artery angioplasty followed by infrainguinal bypass. Despite
earlier concerns about the durability and reliability of an-
gioplasty in the setting of downstream bypass grafts, the
approach is now well accepted and often preferred in the
setting of multilevel disease and limb-threatening ischemia.
The concept of combining angioplasty and surgery as a
single procedure is not new. There are at least 25 published
reports of combined procedures for lower extremity indi-
cations.8-31 Table I summarizes the larger series where
concomitant procedures were performed. In 1981, Fogarty
et al,8 Lowman et al,9 and Motarjeme, Keifer, and Zuska10
separately reported the earliest series of such concomitant
procedures for lower extremity ischemia. Within the com-
bined series of 55 patients, two angioplasty failures, one
embolization, and three hematomas were the only reported
complications. Despite these favorable early results, there
was little enthusiasm for combining the procedures in the
operating room for more than a decade. Putative advan-
tages of separating the procedures have been cited, such as
better imaging in the radiology suite, the ability to assess
hemodynamic results of the angioplasty before more distal
surgery, and (not the least) lack of catheter skills possessed
by vascular surgeons.1,14,18,35,38
In the last decade, vascular surgeons have become
increasingly interested in and experienced with perfor-
mance of transluminal angioplasty and stent procedures.
Numerous reports have documented the safety of perfor-
mance of endovascular procedures by vascular surgeons in
the operating room setting.16,19,22,23,27-30,32,39,40 In the
largest published series to date of comcomitant procedures,
the report of Madera and colleagues27 on angioplasty in the
operating room included 108 combined open and endo-
vascular procedures among 239 endovascular procedures
performed by vascular surgeons on 200 patients. The im-
mediate technical success rate of the angioplasty procedure
was 90%, the highest for proximal lesions. The late patency
rate of the angioplasty site ranged from 58% to 100%, with
inferior results for more distal lesions.
In other smaller series, initial technical success was
similar, but late patency results are less well defined, rang-
Kaplan-Meier plots of estimated primary patency rate (A), assisted
primary patency rate (B), and secondary patency rate (C) for
BYPASS group surgical reconstructions. Grafts or limbs at risk
depicted. Note limb salvage plot includes eight of 73 procedures
done for indications other than limb salvage.
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ing from 029 to 86%19 at 2 years. Whether the cause of late
graft failure could be attributed to failure at the endovas-
cularly treated site was not elucidated in most reports.
Areas of controversy exist. Some investigators have
questioned the appropriateness of vascular surgeons, rather
than interventional radiologists, performing endovascular
procedures.41,42 Some favor a staged approach with prelim-
inary endovascular treatment in the radiology
suite,1,3,36,38,43 with at least the theoretic concern that
suboptimal angioplasty results achieved in the operating
room may compromise graft patency. Finally, we acknowl-
edge that the vascular surgeon’s ability to perform endo-
vascular treatments might bias toward its preferential use
even when open treatment may be more durable. We
therefore questioned whether failure at the angioplasty site
was in fact a frequent cause of late graft failure.
Our immediate results for combined procedures are
similar to those reported by other groups. The 93% (BY-
PASS group) and 88% (REVISION group) initial technical
success rates with the angioplasty procedures may have
been somewhat higher if operative “bail-out” was not a
ready option. Most technical failures were for suboptimal
angioplasty results. We did not exclude these failures from
patency calculations, although it might be argued that such
an intent-to-treat analysis might dilute the true effect of
concomitant endovascular treatment. Because this repre-
sented only 7% of the BYPASS group, the effect, whether
positive or negative, was likely small.
Aside from the conversions to open procedures, there
were no complications specifically attributable to the endo-
vascular procedure itself in either group. Overall morbidity
was as expected for the open surgical procedures alone,
with no discernible added morbidity to combining the
endovascular component.
Analysis of late results is confounded somewhat by the
varying types of grafts and endovascular procedures per-
formed. We acknowledge this limitation of our study—
subgroup analysis was simply not possible for most variables
because of small sample size. However, despite the variabity
of patients and procedures, the overall finding that late graft
failures were infrequently caused by failure at the endovas-
cular site remains valid. Although seven of 23 revisions
performed in the BYPASS group for failing but patent
grafts were in fact for angioplasty site lesions, of 19 late graft
thromboses, in only five was there evidence of restenosis at
the angioplasty site as a potential contributor to graft
occlusion. A more distal angioplasty site was more likely to
be associated with graft thrombosis. Importantly, three of
these five patients had failed to undergo scheduled duplex
scan graft monitoring before graft occlusions, emphasizing
the importance of careful duplex scan surveillance to en-
hance patency results.
The discordance of primary patency and assisted pri-
mary patency results reflects our aggressive treatment of
lesions discovered on duplex scan surveillance. The cumu-
lative assisted primary patency rate of 65.1% at 5 years is
reasonable given the frequency of limb salvage indications,
the prevalence of secondary operations, the multilevel na-
ture of the occlusive disease, the need for prosthetic infrain-
guinal grafts in a substantial minority, and the significant
subset (17.8%) of patients with end stage renal disease.
Although a previous randomized prospective study did
not show superior patency with primary stenting,44 we have
more liberally used stents at the iliac position in recent
years. Timaran et al31 found significantly better bypass
patency in patients with iliac lesions treated with stents
compared with angioplasty alone and concluded that pri-
mary stenting should be performed when a bypass will be
constructed downstream. We were unable to show im-
proved graft patency with stenting, although a trend to-
ward better results was noted.
Our findings in the REVISION group mirrored those
in the BYPASS group, although meaningful life-table anal-
ysis was confounded by the varying age and patency histo-
ries of grafts at the time of the combined procedure.
However, in tracking causes of graft thrombosis observed
in late follow-up, in only three of 22 was there evidence of
stenosis or occlusion at the angioplasty site at the time of
graft occlusion. Again, two of these three cases were over-
due for duplex scan surveillance.
Cost assessment was not a focus of this analysis. It is
difficult to compare costs of sequential versus concomitant
combined treatment, and the comparison greatly depends
on local hospital factors and practices. However, with in-
creasing sophistication of duplex scan and magnetic reso-
nance imaging,45-47 it may be possible to forego diagnostic
arteriography in the radiology suite altogether in some
patients with multilevel disease. This would certainly re-
duce resource utilization.
CONCLUSION
Although limited by the retrospective nature of this
analysis and the heterogenous mix of procedures, our data
support the adjunctive use of endovascular therapies by
vascular surgeons in the operating room when performing
open procedures for multilevel arterial disease. Late graft
thrombosis is infrequently related to failure at the endovas-
cularly treated segment. The combined approach is conve-
nient for the patient, allows immediate treatment for inad-
equate angioplasty results, and may result in less resource
utilization and cost. It is our bias, although not provable
with the available data, that adjunctive inflow procedures
fare better than outflow procedures and that primary stent-
ing of the iliac segment is generally indicated. Careful
postoperative duplex scan surveillance of both the graft and
the endovascular site is crucial to maximizing long-term
success.
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DISCUSSION
Dr Donald P. Spadone (Columbia, Mo). When you are
doing these concomitant procedures, do you do the endovascular
balloon first and then construct your bypass, or do you do the
bypass first? A concern, of course, is clamping and having a static
column of blood in the region where you have done your annulo-
plasty if you are constructing a bypass.
Dr Matthew J. Dougherty. We generally have performed
the endovascular procedure first, and I have not observed throm-
bosis with the use of full heparinization with that approach.
Dr George Andros (Encino, Calif). Your technique for do-
ing these procedures together in the operating room may be moot
once we all have access to the angio suite and can couple the
angiogram to the angioplasty. I would hope that you have a chance
to isolate these two procedures in the future as we have for many
years.
Are you using the classical approach to angioplasty and mea-
suring pressures across the iliac lesion? Are you checking ankle
pressures intraoperatively to see the effect of your intervention on
the SFA occlusions and distal circulation? It is possible that in some
cases you may not need the bypasses.
Dr Dougherty. We do routinely measure pressures, usually
after the bypass is done, with papaverine to uncover any gradient.
Dr Andros. No, I mean the angioplasty, not the bypass.
Dr Dougherty. Yes, the angioplasty site, we routinely mea-
sure pressures to ensure hemodynamic success as well as angio-
graphic success.
And the second part of your question was regarding separating
the procedure, and I think your comment. We feel differently. We
feel that the convenience factor of being able to do this all in one go
is probably helpful. Now, there are occasional patients where you
might choose to separate the procedures if you think an inflow
procedure alone might be sufficient. Many of these patients were
patients with extensive gangrene and ulcers, and we knew that we
were going to have to do both inflow and outflow procedures from
the outset.
Dr Thomas F. O’Donnell, Jr (Boston, Mass). Since your
division has been very interested in hospital costs and there are data
available from your previous studies, could you describe the differ-
ence in length of stay between these patients who had a combined
procedure and those that received a standard infrainguinal bypass?
As a corollary to the question that Dr Andros asked about the
use of angio suite. Once the length of stay is reduced, the prime
driver of costs in vascular procedures becomes the cost of the OR.
People could argue that it is less costly to do the angio dilatation
and stenting in an angio suite and save the OR for the operative
procedure alone. Would you comment?
Dr Dougherty. With regard to your first question, we actu-
ally did not look at length of stay in this rather heterogeneous
group of patients as compared with bypass procedures performed
alone. We did not have any angioplasty-related complications
other than those that were treated immediately in the operating
room, so it seems unlikely that any prolonged length of stay would
be on the basis of the endovascular procedure. However, I think it
is probably entirely possible that these patients have more ad-
vanced disease in general and probably had longer lengths of stay
than the routine, single-level bypass.
With regard to your second question, it is a very difficult issue;
and one of the reasons that cost has not been looked at well is it is
very difficult to get the data. As many of you know, the formula for
assessing charges for angiography suites is completely different
than what is used in the operating room. But I would state that in
general the level of resources utilized in terms of anesthesia support
and other personnel is really pretty similar between the two. And
the big advantage here would be if you can do a single procedure as
opposed to both a diagnostic and a therapeutic procedure at
separate times.
Dr Joerg Dieter Gruss (Kassel, Germany). Did you ever try
to do the endovascular procedure through the prosthetic graft so as
to perform first the proximal or distal anastomosis and then go with
your device through the graft and dilate the artery?
Dr Dougherty. Yes, in fact, that is one of the advantages of
this technique is that you can utilize a healthy graft rather than
sometimes very diseased arteries for your access.
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